Search

everythinglearnresearchcommunity

for

Search:↓

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A person with thyroid problems had rare, swollen, bald spots on their scalp caused by a condition usually found on the shins.

A 27-year-old with APS-1 showed improvement in symptoms after treatment.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Skin problems are common in thyroid disorders, with dry skin in hypothyroidism and warm, soft skin in hyperthyroidism.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

TNF-alpha inhibitors can cause various immune-related skin issues.

People with alopecia areata often have thyroid autoimmunity.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The document is a detailed medical reference on skin and genetic disorders.

Proper periodontal treatment with xenograft effectively manages aggressive periodontitis in SLE patients.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Some antiseizure medications can cause reversible hair loss, with valproate, lamotrigine, and carbamazepine being the most common.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Local inflammation worsens autoimmune skin conditions by increasing antibody buildup.